Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study

Multiple Sclerosis

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study

Neurology.

Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A

doi: 10.1212/

COMMENTED

Multiple Sclerosis

Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden

JAMA Neurol.

Beiki O, Frumento P, Bottai M, Manouchehrinia A, Hillert J

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsMultiple Sclerosis

Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members

JAMA Neurol.

Xia Z, Steele SU, Bakshi A, Clarkson SR, White CC, Schindler MK, Nair G, Dewey BE, Price LR, Ohayon J, Chibnik LB, Cortese IC, De Jager PL, Reich DS

doi: 10.1001/

Multiple Sclerosis

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies

Lancet Neurol.

Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I

doi: 10.1016/

Multiple Sclerosis

Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients

J Neurol Sci.

Heesen C, Kleiter I, Meuth SG, Krämer J, Kasper J, Köpke S, Gaissmaier W

doi: 10.1016/j.jns.2017.03.001.

Psychosis and Schizophrenia

End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database

Lancet Public Health.

Fond G, Salas S, Pauly V, Baumstarck K, Bernard C, Orleans V, Llorca PM, Lancon C, Auquier P, Boyer L

doi: 10.1016/S2468-2667(19)30187-2.

Aging and Cognitive FunctionsMultiple SclerosisDementia

Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study

Lancet.

Chen H, Kwong JC, Copes R, Tu K, Villeneuve PJ, van Donkelaar A, Hystad P, Martin RV, Murray BJ, Jessiman B, Wilton AS, Kopp A, Burnett RT

doi: 10.1016/

SPECIAL REPORT

Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

Multiple Sclerosis

The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study

Pediatr Neurol.

Alroughani R, Ahmed SF, Behbehani R, Al-Hashel J

doi: 10.1016/

Related content

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study

Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden

Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies

Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients

End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database

Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study

Vaccination Readiness in Multiple Sclerosis

The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study